OMCL (Omnicell Corp) רווח נקי למניה (EPS TTM)

The current rolling earnings per share level for Omnicell, Inc. (OMCL) reflects income dynamics where the metric remains around 0.96. Mature medication management solutions are currently being migrated to a cloud-based format. The transition to a SaaS model reduces dependence on clinic capital expenditures, thereby diversifying revenue. Omnicell, Inc. (OMCL) generates profit through the supply of robotic cabinets, intelligent packaging, and specialized pharmacy software.

Omnicell, Inc. (OMCL) long-term pharmacy automation contracts stabilize margins, a trend clearly reflected in the annual net income per share. This indicator measures the business's bottom-line income distributed per common share over the last 12 months, allowing for an assessment of real profit generation efficiency excluding capital dilution and the volatility of one-time expenses.